Loading…
Jerrold B Grossman is Director at ADMA Biologics, Inc.. OQRO lists 5 transactions filed with the SEC under this name, the latest on May 28, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
1
3 buys, median +12.7% vs S&P 500, beat it 3 of 3 times.
Average +12.7% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed May 12, 2026 to May 28, 2026, measured from the first close after the filing. Past results, not a forecast.
ADMA Biologics, Inc.ADMA
5 disclosures · Feb 2026 – May 2026 · 3 bought
May 27, 2026Bought~$51Kdisclosed May 28
DetailsOfficial recordMay 12, 2026Bought~$100Kdisclosed May 14
DetailsMay 11, 2026Bought~$100Kdisclosed May 12
DetailsOfficial recordFeb 9, 202611Kdisclosed Feb 12
DetailsOfficial recordFeb 9, 202618Kdisclosed Feb 12
DetailsOfficial record